Related Experiment Video
Updated: Dec 13, 2025

05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
512
Perceptions about cannabis use during pregnancy: a rapid best-framework qualitative synthesis
Sarah J Weisbeck1, Katherine S Bright1, Carla S Ginn2
1Faculty of Nursing, University of Calgary, 2500 University Dr. N.W, Calgary, AB, T2N 1N4, Canada.
Summary
Women using cannabis during pregnancy often underestimate risks due to perceived benefits and lack of provider communication. Improved patient-provider discussions on cannabis use are crucial for informed decision-making.
Area of Science:
- Perinatal Health
- Substance Use Research
- Reproductive Health
Background:
- Understanding pregnant women's perceptions of cannabis risks is vital for public health initiatives.
- Cannabis use during pregnancy remains a significant concern with evolving legal and social contexts.
- Existing research often overlooks nuanced beliefs influencing maternal health decisions.
Approach:
- A rapid review systematically synthesized qualitative and descriptive studies on pregnant women's cannabis use perceptions.
- Databases searched included MEDLINE, EMBASE, PsycINFO, and CINAHL up to March 2019.
- Five studies meeting inclusion criteria were appraised for methodological quality.
Key Points:
- Pregnant women using cannabis frequently perceived lower risks compared to non-users.
- Uncertainty about adverse effects, perceived therapeutic benefits, and limited healthcare provider communication influenced continued use.
- Women interpreted a lack of professional guidance as an indicator of minimal risk associated with prenatal cannabis exposure.
Conclusions:
- Healthcare providers play a critical role in educating childbearing women about the risks of cannabis use during pregnancy.
- Open communication and counseling can significantly influence women's risk perception and support informed decision-making regarding substance use.
- Addressing women's beliefs and knowledge gaps is essential for effective interventions aimed at reducing adverse perinatal outcomes.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
570
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
570
Hallucinogens and Psychedelics
461
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
461
Teratogenicity
3.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K

